Allan J. Fischman

Allan J. Fischman's AcademicInfluence.com Rankings

Allan J. Fischman

Philosophy

#7721

World Rank

#10972

Historical Rank

Logic

#4761

World Rank

#6089

Historical Rank

philosophy Degrees

Allan J. Fischman

Biology

#10429

World Rank

#13759

Historical Rank

Biochemistry

#1642

World Rank

#1777

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Allan J. Fischman's Degrees

PhD Biochemistry Stanford University
Doctorate Medicine Stanford University

Why Is Allan J. Fischman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Allan J. Fischman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (2004) (1997)
A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. (1996) (977)
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. (2006) (896)
Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. (1994) (841)
Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. (2004) (771)
Impaired recruitment of the hippocampus during conscious recollection in schizophrenia (1998) (592)
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. (2009) (519)
The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? (1994) (453)
Imaging amyloid deposition in Lewy body diseases (2008) (434)
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. (2005) (429)
Self-organized patchiness in asthma as a prelude to catastrophic shifts (2005) (414)
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy (2007) (398)
The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation (1997) (373)
P2-366 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees (2006) (367)
Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. (2007) (355)
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. (1990) (355)
Susceptibility contrast imaging of cerebral blood volume: Human experience (1991) (307)
A positron emission tomographic study of simple phobic symptom provocation. (1995) (283)
Anger in healthy men: a PET study using script-driven imagery (1999) (278)
Hippocampal function in posttraumatic stress disorder (2004) (261)
A PET investigation of implicit and explicit sequence learning (1995) (252)
Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET (2009) (247)
A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. (2006) (244)
Activation of anterior paralimbic structures during guilt-related script-driven imagery (2000) (244)
Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. (1997) (239)
Porcine Xenografts in Parkinson's Disease and Huntington's Disease Patients: Preliminary Results (2000) (229)
Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. (1995) (229)
Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans. (2002) (228)
FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. (2002) (209)
111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. (1989) (205)
Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. (1999) (196)
Prefrontal regions supporting spontaneous and directed application of verbal learning strategies: evidence from PET. (2001) (196)
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. (2003) (194)
Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience. (2006) (182)
A ticket to ride: peptide radiopharmaceuticals. (1993) (179)
High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. (2000) (171)
Simplified measurement of deoxyglucose utilization rate. (1996) (170)
Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. (1990) (170)
Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. (1999) (170)
Predictors of Fluvoxamine Response in Contamination-related Obsessive Compulsive Disorder: A PET Symptom Provocation Study (2002) (163)
Neural Correlates of Factor-Analyzed OCD Symptom Dimensions: A PET Study (1998) (162)
Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. (2009) (160)
Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks. (2004) (155)
Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia (2003) (148)
Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. (1998) (141)
Imaging Human Atherosclerosis with 99mTc‐labeled Low Density Lipoproteins (1988) (141)
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder (2001) (137)
Neural activation during sexual and competitive arousal in healthy men (1999) (133)
Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. (1995) (130)
Quantification of regional ventilation-perfusion ratios with PET. (2003) (129)
Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. (1991) (128)
A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems (2003) (127)
Resting metabolic activity in the cingulate cortex and vulnerability to posttraumatic stress disorder. (2009) (127)
FDG-PET is Superior to Gallium Scintigraphy in Staging and More Sensitive in the Follow-up of Patients with de novo Hodgkin Lymphoma: A Blinded Comparison (2004) (125)
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies. (2001) (124)
Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. (2008) (123)
Robot‐aided functional imaging: Application to a motor learning study (1998) (121)
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. (2002) (121)
Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters (1998) (118)
Improved Methods for Image Registration (1996) (118)
Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. (1994) (118)
Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. (2004) (118)
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. (2005) (112)
Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia (2000) (112)
CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder (2012) (109)
Bowel hot spots at PET-CT. (2007) (107)
Using imaging biomarkers to accelerate drug development and clinical trials. (2005) (106)
Striatal dopamine release in sequential learning (2007) (105)
Regional cerebral brain metabolism correlates of neuroticism and extraversion (2006) (105)
Value of PET in the assessment of patients with neurofibromatosis type 1. (2007) (103)
Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT. (2006) (103)
Detection of acute inflammation with 111In-labeled nonspecific polyclonal IgG. (1988) (100)
Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. (1995) (100)
Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. (1993) (96)
PET–CT vs. CT alone in ovarian cancer recurrence (2007) (96)
Neural substrates of anorexia nervosa: a behavioral challenge study with positron emission tomography. (2001) (94)
Echo-Planar MR Cerebral Blood Volume Mapping of Gliomas (1995) (93)
Radiolabeled, nonspecific, polyclonal human immunoglobulin in the detection of focal inflammation by scintigraphy: comparison with gallium-67 citrate and technetium-99m-labeled albumin. (1989) (91)
Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. (1991) (91)
Homocysteine impairs coronary microvascular dilator function in humans. (2002) (91)
Effect of "co-ligand" on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. (1995) (90)
FDG-PET in oncology: there's more to it than looking at pictures. (1993) (88)
Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. (1990) (85)
Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon. (2001) (83)
Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography (1993) (83)
Pharmacokinetic Imaging (2002) (82)
Development of a small animal PET imaging device with resolution approaching 1 mm (1999) (75)
False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. (2004) (75)
Flare response in 18F-fluoride ion PET bone scanning. (2006) (75)
Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. (2005) (73)
Improved Radiologic Staging of Lung Cancer with 2-[18F]-Fluoro-2-Deoxy-d-Glucose–Positron Emission Tomography and Computed Tomography Registration (2003) (73)
Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues. (1996) (70)
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. (1993) (70)
Impaired Recruitment of the Dorsolateral Prefrontal Cortex and Hippocampus During Encoding in Bipolar Disorder (2006) (69)
A PET Study of Tiagabine Treatment Implicates Ventral Medial Prefrontal Cortex in Generalized Social Anxiety Disorder (2009) (68)
Synthesis and Characterization of Organohydrazino Complexes of Technetium, Rhenium, and Molybdenum with the {M(eta(1)-H(x)()NNR)(eta(2)-H(y)()NNR)} Core and Their Relationship to Radiolabeled Organohydrazine-Derivatized Chemotactic Peptides with Diagnostic Applications. (1998) (68)
Dopamine release during human emotional processing (2009) (67)
In vivo imaging of neuromodulation using positron emission tomography: Optimal ligand characteristics and task length for detection of activation (1995) (66)
In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. (1993) (65)
FDG-PET and CT features of non-small cell lung cancer based on tumor type. (2007) (64)
Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. (1994) (64)
FDG PET characterization of renal masses: preliminary experience. (1997) (64)
Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit. (1993) (63)
Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone. (1996) (63)
Optimal CT breathing protocol for combined thoracic PET/CT. (2006) (63)
In vivo imaging of neuromodulatory synaptic transmission using PET: A review of relevant neurophysiology (1995) (62)
Technetium-99m-labeled white blood cells: a new method to define the local and systemic role of leukocytes in acute experimental pancreatitis. (1998) (62)
Liver Lesion Detection and Characterization in Patients With Colorectal Cancer: A Comparison of Low Radiation Dose Non-enhanced PET/CT, Contrast-enhanced PET/CT, and Liver MRI (2008) (62)
Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy. (1993) (60)
Decreased regional cerebral blood flow in medial prefrontal cortex during trauma-unrelated stressful imagery in Vietnam veterans with post-traumatic stress disorder (2011) (60)
Neuroanatomy of human appetitive function: A positron emission tomography investigation. (2000) (60)
Single photon emission computed tomography perfusion differences in mild cognitive impairment (2006) (58)
Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G. (1989) (57)
Metabolic Tumor Width Parameters as Determined on PET/CT Predict Disease-free Survival and Treatment Response in Squamous Cell Carcinoma of the Esophagus (2008) (57)
The role of positron emission tomography in pharmacokinetic analysis. (1997) (55)
High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. (2005) (55)
Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa (2004) (55)
Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy. (1993) (54)
Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain (1998) (53)
Striatal dopamine release during unrewarded motor task in human volunteers (2003) (53)
Infection imaging with technetium-99m-labeled chemotactic peptide analogs. (1994) (52)
[11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites (2001) (52)
Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. (1996) (51)
Evaluation of Rare Tumors with [F-18]Fluorodeoxyglucose Positron Emission Tomography. (1999) (51)
Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates. (1998) (50)
Pharmacokinetics of [18F]Trovafloxacin in Healthy Human Subjects Studied with Positron Emission Tomography (1998) (50)
The use of radiolabeled nonspecific immunoglobulin in the detection of focal inflammation. (1994) (49)
Evaluation of (4-[18F]Fluorophenyl)triphenylphosphonium Ion. A Potential Myocardial Blood Flow Agent for PET (2011) (49)
Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism. (1998) (48)
Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. (1997) (47)
Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging. (1998) (46)
Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT (2006) (46)
Mapping of local renal blood flow with PET and H(2)(15)O. (2002) (45)
Complications of exercise and pharmacologic stress tests: Differences in younger and elderly patients (1999) (45)
Neutrophil metabolic activity but not neutrophil sequestration reflects the development of pancreatitis-associated lung injury* (2002) (45)
Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. (2008) (44)
Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography (1993) (43)
Renal oncocytoma displaying intense activity on 18F-FDG PET. (2006) (43)
Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C‐CFT (1996) (41)
Normal post-race antimyosin myocardial scintigraphy in asymptomatic marathon runners with elevated serum creatine kinase MB isoenzyme and troponin T levels. Evidence against silent myocardial cell necrosis. (1995) (41)
Altropane, a SPECT or PET imaging probe for dopamine neurons: II. distribution to dopamine‐rich regions of primate brain (1998) (41)
Altropane, a SPECT or PET imaging probe for dopamine neurons: I. dopamine transporter binding in primate brain (1998) (40)
Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease. (1996) (40)
Thymic enlargement and FDG uptake in three patients: CT and FDG positron emission tomography correlated with pathology. (2003) (40)
Explicit motor memory activates the striatal dopamine system (2008) (39)
SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys. (1997) (39)
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding (2002) (39)
Synthesis of a macromolecular camptothecin conjugate with dual phase drug release. (2004) (39)
Improved image interpretation with registered thoracic CT and positron emission tomography data sets. (2002) (39)
Utility of the indium 111-labeled human immunoglobulin G scan for the detection of focal vascular graft infection. (1989) (37)
Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization. (1994) (37)
Quantitative PET measurements of regional myocardial blood flow: observations in humans with ischemic heart disease. (1997) (37)
Multimodal Longitudinal Imaging of Focal Status Epilepticus (2004) (37)
Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging. (2005) (37)
Lipomatous hypertrophy of the interatrial septum: prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT. (2005) (36)
Evaluation of pancreatic carcinoma with FDG PET (2001) (36)
Myelofibrosis on F-18 FDG PET Imaging. (2005) (36)
Comparison of alignment of computer-registered data sets: combined PET/CT versus independent PET and CT of the thorax. (2005) (36)
FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. (1997) (35)
CORRIGENDUM: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (2004) (35)
Detection of inflamed atherosclerotic lesions with diadenosine-5′,5‴-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography (2006) (34)
Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury (1991) (33)
The use of pentafluorophenyl derivatives for the 18F labelling of proteins. (1994) (33)
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. (2006) (33)
Positron emission tomography in the clinical evaluation of metastatic cancer. (1996) (33)
Comparison of Two Compartmental Models for Describing Receptor Ligand Kinetics and Receptor Availability in Multiple Injection PET Studies (1996) (32)
Accumulation of immunoglobulin G at focal sites of inflammation (2004) (32)
Effect of carbohydrate modification on the localization of human polyclonal IgG at focal sites of bacterial infection. (1992) (32)
Free radical-mediated membrane depolarization in renal and cardiac cells. (1987) (31)
Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications. (2003) (31)
Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites. (1996) (31)
Relation between coronary "steal" and contractile function at rest in collateral-dependent myocardium of humans with ischemic heart disease. (1999) (31)
Accumulation of Native and Methylated Low Density Lipoproteins by Healing Rabbit Arterial Wall (1987) (31)
Evaluation of prefrontal–hippocampal effective connectivity following 24 hours of estrogen infusion: An FDG-PET study (2008) (31)
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography demonstration of estrogen negative and positive feedback on luteinizing hormone secretion in women. (2008) (31)
Quo vadis radioimmune imaging. (1989) (31)
Muscle protein synthesis by positron-emission tomography with L-[methyl-11C]methionine in adult humans. (1998) (30)
Psychosis of Alzheimer's disease: Gender differences in regional perfusion (2008) (30)
Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography (1992) (30)
Role of [18F]-dopa-PET imaging in assessing movement disorders. (2005) (30)
Is PET-CT the only option? (2007) (30)
Evidence of reduced resting blood flow in viable myocardial regions with chronic asynergy. (2000) (30)
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. (1998) (29)
Pattern of changes over time in myocardial blood flow and microvascular dilator capacity in patients with normally functioning cardiac allografts. (1998) (29)
Pharmacokinetics of 18F-labeled fluconazole in rabbits with candidal infections studied with positron emission tomography. (1991) (28)
Alterations in regional ventilation, perfusion, and shunt after smoke inhalation measured by PET. (2002) (28)
Measurement of muscle protein synthesis by positron emission tomography with L-[methyl-11C]methionine. (1996) (28)
Comparison of the infection imaging properties of a 99mTc labeled chemotactic peptide with 111In IgG. (1995) (28)
Evaluation of pancreatic carcinoma with FDG PET (2001) (27)
Myocardial adaptation during and after sustained, demand-induced ischemia. Observations in closed-chest, domestic swine. (1996) (27)
Localization of technetium-99m-glucarate in zones of acute cerebral injury. (1991) (27)
Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography (1996) (26)
Correlation of FDG-PET interpretation with survival in a cohort of glioma patients. (2004) (26)
Chemotactic peptide uptake in acute pancreatitis: correlation with tissue accumulation of leukocytes. (1999) (26)
Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. (2008) (25)
Gated blood pool tomography: a technology whose time has come. (1989) (25)
18F-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219). (1996) (25)
Evaluation of cerebral pharmacokinetics of the novel antidepressant drug, BMS-181101, by positron emission tomography. (1996) (25)
Performance evaluation of MMP-II:A second-generation small animal PET (2004) (24)
Cardiac blood-pool scintigraphy in rats and hamsters: comparison of five radiopharmaceuticals and three pinhole collimator apertures. (1991) (23)
Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma. (1996) (23)
Synthesis of [11C]dapoxetine.HCl, a serotonin re-uptake inhibitor: biodistribution in rat and preliminary PET imaging in the monkey. (1994) (23)
Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT. (2000) (22)
Synthesis of 18F-labeled fluconazole and positron emission tomography studies in rabbits. (1992) (22)
Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells (1997) (21)
Localization of indium-111-immunoglobulin G, technetium-99m-immunoglobulin G and indium-111-labeled white blood cells at sites of acute bacterial infection in rabbits. (1993) (21)
Synthesis, characterization, and biodistribution of a Technetium-99m ‘3+1’ fatty acid derivative. The crystal and molecular structures of a series of oxorhenium model complexes (2002) (21)
Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer (2008) (21)
Evaluation of ventricular function in patients with coronary artery disease. (1989) (21)
Averaging of φ2 and φ3 in [5‐leucyl]‐enkephalin (1978) (20)
Semisynthetic hydrophilic polyals. (2005) (20)
How well can radiologists using neural network software diagnose pulmonary embolism? (2000) (20)
Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease? (2001) (20)
Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. (1993) (20)
Imaging of Pneumocystis carinii pneumonia with 111In‐labelled non‐specific polyclonal IgG: an experimental study in rats (1991) (20)
Morphologic and functional correlates of plasma membrane injury during oxidant exposure. (1989) (20)
Fluorodeoxyglucose Positron Emission Tomography Pattern of Pulmonary Lymphangitic Carcinomatosis (2005) (19)
Synthetic copolymer kit for radionuclide blood-pool imaging. (1994) (19)
Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor. (2008) (18)
99mTc-labeled chemotactic peptides: influence of coligand on distribution of molecular species and infection imaging properties. Synthesis and structural characterization of model complexes with the {Re(η2-HNNC5H4N)(η1-NNC5H4N)} core (2000) (18)
Effects of sildenafil on myocardial blood flow in humans with ischemic heart disease (2005) (18)
Nuclear imaging in the genitourinary tract: recent advances and future directions. (2008) (17)
Fully degradable hydrophilic polyals for protein modification. (2005) (17)
Synthesis and biodistribution of a new 99mtechnetium fatty acid. (1994) (17)
Cardiac blood-pool imaging. II: Applications in noncoronary heart disease. (1990) (17)
Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors. (1999) (16)
FDG-PET CT for tumor imaging. (2007) (16)
Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy (2006) (16)
Synthesis of a 11C-labeled NK1 receptor ligand for PET studies. (1995) (15)
Meteorologic influences on the frequency of pulmonary embolism. (1992) (15)
Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG. (1996) (15)
FDG-PET analysis of amygdalar-cortical network covariance during pre- versus post-menopausal estrogen levels: potential relevance to resting state networks, mood, and cognition. (2008) (15)
HIV-associated myositis detected by radionuclide bone scanning. (1989) (15)
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer? (2004) (15)
N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides. (2005) (14)
Detection of acute bacterial infection within soft tissue injuries using a 99mTc-labeled chemotactic peptide. (1995) (14)
Radionuclide imaging of infection in the immunocompromised host. (1996) (14)
Photosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorin(e6). (2006) (14)
Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands. (2000) (14)
Hybrid PET/CT of the Thorax: When Is Computer Registration Necessary? (2007) (13)
Myocardial extraction of 1-[11C] betamethylheptadecanoic acid. (1994) (13)
Preparation and pharmacokinetics of 11C labeled stavudine (d4T). (2004) (13)
Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT (2009) (13)
Effect of isoelectric point on biodistribution and inflammation imaging with indium-111-labelled IgG (2004) (13)
In Vivo Imaging in Drug Discovery and Design (1994) (13)
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT®-Tc), a totally human monoclonal antibody (1998) (13)
Radionuclide imaging of sequential torsions of the appendix testis. (1987) (13)
Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET. (1993) (13)
Pearls and Pitfalls in Interpretation of Abdominal and Pelvic (2006) (12)
Comparison of standard-dose vs low-dose attenuation correction CT on image quality and positron emission tomographic attenuation correction. (2008) (12)
Cardiovascular nuclear medicine: the next step. (1989) (12)
Quantitative measurements of medical images for pharmaceutical clinical trials: comparison between on-site and off-site assessments. (2000) (12)
FDG PET Characterization of Renal Masses Preliminary Experience (1998) (11)
Effects of nifedipine on myocardial blood flow and systolic function in humans with ischemic heart disease. (1999) (11)
Probing striatal function in obsessive compulsive disorder using PET and a sequence learning task (1996) (11)
Thallium imaging, dobutamine echocardiography and positron emission tomography for the assessment of myocardial viability (1996) (10)
Performance of a novel collimator for high-sensitivity brain SPECT. (2005) (10)
Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography. (1997) (10)
Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer (2013) (10)
Imaging the ovine heparin-protamine interaction with 111In-protamine. (1993) (10)
Performance of small animal PET instrument with 1 mm resolution (1999) (9)
with Coronary Artery Disease (1989) (9)
Who should read and interpret 18F-FDG PET studies? (2003) (9)
6-Mercaptomethylpyridine-3-carboxylic acid (MEMNIC): a new reagent for peptide labeling with Tc-99m (2001) (9)
In vivo tissue distribution of CD4 lymphocytes in mice determined by radioimmunoscintigraphy with an 111In-labeled anti-CD4 monoclonal antibody. (1996) (9)
Regional perfusion, oxygen metabolism, blood volume and immunoglobulin G accumulation at focal sites of infection in rabbits (2004) (8)
Comparison of 99Tcm-labelled monoclonal anti‐granulocyte antibody and 111 In‐labelled IgG for the detection of focal sites of infection in rats (1991) (8)
Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography. (1997) (8)
Myocardial flow regulation in people with mitochondrial myopathy, encephalopathy, lactic acidosis, stroke‐like episodes/myoclonic epilepsy and ragged red fibers and other mitochondrial syndromes (2003) (8)
Technetium-99 m-Labeled White Blood Cells A New Method to Define the Local and Systemic Role of Leukocytes in Acute Experimental Pancreatitis (2005) (7)
Uridine: A marker of myocardial viability after coronary occlusion and reperfusion (1993) (7)
New radionuclides for cardiac imaging. (1986) (7)
Indium-111 DTPA-heparin: radiolabeling, pharmacokinetics, and biodistribution following intravenous administration in rat and rabbit. (1998) (7)
Serial course of left ventricular function, perfusion and fatty acid uptake in the cardiomyopathic hamster. (1993) (7)
Imaging of focal sites of inflammation in rhesus monkeys with 99mTc-labeled human polyclonal IgG. (1994) (6)
External Imaging of Active Atherosclerosis with 99mTc-LDL (1990) (6)
Regional pharmacokinetics of orally administered PET tracers. (2000) (6)
PET imaging of brain tumors. (2008) (6)
Positron emission tomographic analysis of central dopamine D1 receptor binding in normal subjects treated with the atypical neuroleptic, SDZ MAR 327. (1998) (6)
Functional imaging of neurotransmission (2007) (6)
Synthesis and evaluation of novel-N-[2-(bis-aryl-methoxy)ethyl-N'-aralkyl-α,ω-alkanediamines as potent and selective dopamine reuptake inhibitors : SECO analogs of GBR12935 and GBR12909 (1997) (5)
Biological target volume (BTV) determined with dose response data from the correlation between metabolic rate of glucose (MRG) measured with 18F-FDG PET and pathologic complete response (PCR) in stage III non-small cell lung cancer (NSCLC) (2000) (5)
Reciprocal Lateralization of Frontal Lobe Functions-Reply (1995) (5)
Positron emission tomography in drug development. (1997) (5)
"Hot" spots in hybrid positron emission tomography/computed tomography scanning of the abdomen: protocols, indications, interpretation, responsibilities, and reimbursements. (2006) (5)
A phase I study evaluating dosimetry and myocardial pharmacokinetic behavior of BFPET, a new F-18 labeled tracer for myocardial perfusion imaging (2009) (5)
Diagnosis of Acute Myocarditis with Radiolabeled Monoclonal Antimyosin Antibody: Immunoscintigraphic Evaluation (1988) (5)
Reliability of radionuclide scintigraphy for detection of testicular torsion: an animal study (2005) (4)
Polyclonal, nonspecific 111In-IgG scintigraphy in the evaluation of complicated osteomyelitis and septic arthritis. (1999) (4)
A systemic route for drug loading to lymphatic phagocytes. (2005) (4)
V 1 Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82 Rb PET : Comparison with 13 N-Ammonia (2009) (4)
Novel (bisarylmethoxy)butylpiperidine analogues as neurotransmitter transporter inhibitors with activity at dopamine receptor sites. (2002) (4)
Tissue pharmacokinetics of fleroxacin in humans as determined by positron emission tomography. (1994) (4)
Laparoscopic scar: a mimicker of Sister Mary Joseph's nodule on positron emission tomography/CT. (2006) (4)
Localization of [125I]endothelin-1 in injured aorta of rabbits. (1995) (4)
Use of positron emission tomography to study tumors in vivo. (1996) (4)
Role of FLT PET in Supplementing FDG PET for Robust Classification of Metabolic Response Even in the Presence of Coexisting Pneumonitis in Radiotherapy or Chemoradiotherapy for Lung Cancer (2011) (4)
Analysis of prefrontal-hippocampal effective connectivity during estrogen infusion: An FDG-PET study (2008) (4)
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET. (2005) (3)
Role of FDG PET in the Evaluation of Rare Tumors. (1998) (3)
Clinical PET--a modest proposal. (1991) (3)
Phenothiazine-mediated depolarization of the plasma membrane in a renal cell line. (1988) (3)
Non-tumor applications of radioimmune imaging. (1991) (3)
MER-1001, a novel polymeric prodrug of camptothecin, is a potent inhibitor of LS174 and A2780 human tumor xenografts in a mouse model (2007) (3)
Images in cardiovascular medicine. Complementary role of multimodality imaging in the evaluation of intracardiac lymphoma in an HIV-infected man. (2007) (3)
Imaging of brain tumors (1994) (3)
Functional MRI and PET FDG studies: Correlations with glial tumor prognosis (1992) (3)
Synthesis and biodistribution of F-18 labeled scyllo-inositol derivatives as potential probes for detecting amyloid beta oligomers (2009) (3)
503 5HT2 and D2 receptor occupancy of ziprasidone in healthy volunteers (1997) (3)
P-17-2 Sustained 5HT2A receptor occupancy of ziprasidone using pet ligand 18F setoperone in healthy volunteers (1996) (3)
Detection of task-induced release of extrastriatal dopamine using fallypride (2007) (2)
Abstract 2331: Detection of Inflamed Coronary Culprit Lesions in Patients using PET-CT (2007) (2)
Chapter 82 - PET Imaging of Neuromodulation Designing Experiments to Detect Endogenous Transmitter Release (1996) (2)
Striatal dopamine release during emotional memory processing (2007) (2)
A linear model for characterizing neurotransmitter release dynamics from PET data (2007) (2)
Evaluation of phenylpiperazines as targeting agents for neuroblastoma. (1996) (2)
Novel 3‐Aminomethyl‐ and 4‐Aminopiperidine Analogues of 1‐[2‐(Diphenylmethoxy)ethyl]‐4‐(3‐phenylpropyl)piperazines: Synthesis and Evaluation as Dopamine Transporter Ligands. (2000) (2)
[N-2[18F]Fluoropropyl]2-(4'(methylamino)phenyl)-6-hydroxybenzothiazole for potential A{beta} amyloid imaging (2007) (2)
AbstractYoung investigator competition24.04: Vascular FDG-PET measurements correlate with histologically-determined inflammation in the contralateral vessel (2006) (2)
Pancreatic Imaging with 11C-Dihydrotetrabenazine PET: A Perspective (2009) (2)
CHAPTER 63 – Estimation of Binding Potential for the 5HT2 Receptor Ligand [18F]Setoperone by a Noninvasive Reference Region Graphical Method (1998) (2)
O4-06-06 Combined dopamine transporter and FDG pet in DLB, AD, and PD (2004) (2)
Integration of robotic technology with functional imaging (1996) (2)
Tc-99m-labeled Ap4A for early gamma scintigraphic visualization of experimental atherosclerotic lesions (1996) (2)
2.34: Problematic interpretation of inferior ischemia: A pilot study for investigation of underlying coronary artery disease (2006) (2)
Morphological & functional characterization of mucinous lesions of pancreas: Is the combination PET-CT better than MDCT or PET alone? (2008) (2)
Evaluation of 1-deoxy-1-[18F]fluoro-D-mannitol as a brain imaging tracer for measuring osmotic disruption following cancer therapy (2014) (2)
Synthesis and structural characterization of the neutral indium (III) thiolate species In{(SCH2CH2)3N} (1998) (2)
Phase I and Pharmacokinetic Study of Ecteinascidin 743 Administered as a 72-Hour Continuous Intravenous Infusion in Patients with Solid Malignancies 1 (2001) (2)
Sustained 5HT2A Receptor Occupancy of Ziprasidone Using Pet Ligand 18f Setoperone in Healthy Volunteers (1996) (2)
PET as a biomarker of the antitumor effects of the CDK2 inhibitor BMS-387032. (2004) (2)
IC-103-04 Amyloid burden correlates with cognitive function in normal aging, MCI and AD (2006) (2)
2.33: Diagnostic accuracy of adenosine stress testing with supplemental arm exercise (2006) (1)
Radionuclide imaging of the heart (1991) (1)
Evaluation of 2-[18F]fluoro-2-deoxy-L-glucose for imaging focal areas of inflammation with PET (2011) (1)
Functional recovery of impaired left ventricular function following revascularization: predictive value of dual energy single photon emission computed tomography with fluorine-18-deoxyglucose and Technetium-99m-sestamibi (1998) (1)
Indium-111 DTPA-heparin: pharmacokinetics and biodistribution following subcutaneous administration in rat and rabbit. (1997) (1)
P.7.c.005 Pharmacokinetics, detection, likeability and dislikeability of two formulations of long-acting oral methylphenidate (2006) (1)
Performance evaluation of a second generation small animal PET (2002) (1)
Reply to “PET concerns in bevacizumab treatment” (2004) (1)
A phase I study to evaluate the safety and biodistribution of CardioPET as a new cardiac PET tracer: Studies in normal subjects (2008) (1)
Imaging Techniques in Pharmacology (1991) (1)
IC-P-016 Imaging of cerebral amyloid angiopathy with Pittsburgh compound B (2006) (1)
IC-P2-077: Amyloid deposition related to cortical thinning (2008) (1)
Accumulation of a novel macrophage-targeting photodynamic compound within lipid-rich atherosclerotic plaques (2002) (1)
Molecular MR imaging of labeled stem cells in a mouse burn model in vivo (2009) (1)
Muscle protein synthesis by positron-emission tomography with L-[ methyl-11 C ] methionine in adult humans ( skeletal muscle y fractional synthesis rate ) (1998) (1)
Regional Cerebral Blood Flow Differences During High-Caloric Food Challenge in Patients with Anorexia Nervosa Versus Normal Controls • 9 (1998) (1)
Effect of monounsaturation of a branched fatty acid on organ selectivity. (1995) (1)
Amyloid imaging of cerebral amyloid angiopathy (2007) (1)
Amyloid deposition and cortical thickness in aging and Alzheimer's disease (2008) (1)
ABSTRACTS-Hypertension, Vascular Disease, and Prevention (2016) (1)
Radionuclide imaging probes for expressed proteins (1999) (1)
Role of Positron Emission Tomography Imaging in the Surgical Management of Peripheral Nerve Sheath Tumors in Patients with Neurofibromatosis Type 1 (2007) (1)
Analyzing PET Receptor Studies of Multiple Injections of Varying Specific Activities (1996) (1)
Quasi-continous detector module design for high-resolution small animal PET (2003) (1)
Synthesis of 2-[18F]fluoro-2-deoxy-L-glucose and positron emission tomography studies in monkeys. (1994) (1)
Radionuclide imaging of infection in soft tissue and bone. (1997) (0)
Monitoring of drug concentration in the cerebrospinal fluid by PET (2013) (0)
P1-221: Amyloid deposition related to cortical thinning (2008) (0)
Biodistribution of CardioPET as a PET tracer for estimating and differentiating fat deposit function in mice (2008) (0)
Evaluation of 18-F Fluorothymidine (FLT) PET scanning in patients with pancreatic cancer (2007) (0)
Myocardial accumulation and clearance of technetium 99m Teboroxime at 100%, 75%, 50% and zero coronary blood flow in dogs (2004) (0)
Coincidence measurements with a quasi-continuous detector for small animal PET (2005) (0)
Amyloid imaging with PIB associated with impaired memory function on fMRI (2007) (0)
FDG Uptake at Sequential Intervals After Radiotherapy (RT) or RT of Chemo-Radiotherapy (CT+RT) and its Predictive Value for Tumor Control Probability (TCP) of Metastatic Lung Cancer in Regional Lymph Nodes (2007) (0)
Using image-derived radioactivity as a substitute for venous blood sampling when measuring fluoro-deoxy-glucose utilization rate with the simplified kinetic method in 18F-FDG PET (2007) (0)
The effects of resolution recovery on estimation of binding potential from brain SPECT images (2002) (0)
Cognitive reserve mediates amyloid-related cognitive impairment (2008) (0)
Fluorine-18 labeled FP-21399 for lymph node PET imaging (2007) (0)
Labeled chemotactic peptides for visualization of inflammation and infection sites. (1990) (0)
FDG Uptake Quantified with FDG PET 10-12 Days after Radiotherapy or Chemoradiotherapy in Lung Cancer is Molecular-Biomarker Capable for Predicting Therapy Outcome and Identifying Patients in Need for Timely Salvage Therapy (2010) (0)
Esophagitis Identified in Restaging FDG-PET after Radiotherapy or Chemo-radiotherapy in Lung Cancer (2008) (0)
704-1 Relationship Between Regional Myocardial Blood Flow and Regional Wall Motion at Rest and with Stress in Humans with Chronic Ischemic Heart Disease (1995) (0)
20 Use of the functional imaging modalities, f MRI r CBV and PET FDG, alters radiation therapy 3-D treatment planning in patients with malignant gliomas (1995) (0)
Quantitative mapping of extrastriatal dopamine transporters in normal human subjects (2007) (0)
Natural history of changes in minimal coronary vascular resistence in cardiac allograft recipients (1997) (0)
CHAPTER 49 – Analyzing PET Receptor Studies of Multiple Injections of Varying Specific Activities: Proper Modeling of the Unlabeled Ligand in Blood and Tissue (1996) (0)
Radiation Esophagitis Graded With Common Terminology Criteria for Adverse Events (CTCAE) Revisited With 10 Days and 3 Months Posttherapy 18F-FDG Positron Emission Tomography in Lung Cancer (2016) (0)
Pharmacokinetics of macromolecules in spinal CSF: PET and modeling (2013) (0)
PET imaging of macromolecule and particle delivery to the brain through intrathecal administration in rodents and non-human primates (2012) (0)
Cortical activations, psychiatric symptoms, and climacteric women. (2006) (0)
Myocardial accumulation and clearance of technetium 99m Teboroxime at 100%, 75%, 50% and zero coronary blood flow in dogs (2004) (0)
A phase I study evaluating myocardial pharmacokinetic behavior of CardioPET, a new cardiac PET tracer, in normal subjects and subjects with stable coronary artery disease (2008) (0)
848-4 Noninvasive characterization of carotid plaque inflammation in humans with FDG-positron emission tomography (2004) (0)
Pharmacokinetics of a novel camptothecin conjugate (PHF-CPT) with dual-phase drug release (2007) (0)
O1-05-01 Cortical amyloid deposition related to failure of hippocampal activation (2007) (0)
Detection and treatment of sensitive plaque with photodynamic compounds (2002) (0)
The labeled chemotactic peptides of infection or inflammation of the entries describe the (1996) (0)
Assessment of CSF drainage to the lymphatic system using positron emission tomography in rats and nonhuman primates. (2013) (0)
Dose response relationship between PET-FDG uptake after chemo-radiotherapy (CT + RT) and histopathologic tumor control probability (pTCP) in stage III non-small cell lung cancer (NSCLC) (2000) (0)
Incidence of extra-abdominal metastases and value of WB PET or WB PET/CT in the initial follow-up of patients with colorectal cancer (2006) (0)
Synthesis and evaluation of a series of scyllo-inositol/2-(fluoroethyl)-8-methyl-2,8-diazaspiro[4,5]decane-1,3-dione combined derivatives as potential amyloid-beta polymerization inhibitors and PET oligomer-Abeta probes (2010) (0)
Progress in the development of a 1 mm small animal PET imaging device (1998) (0)
Correlation between the simplified kinetic method and standard uptake value in lung cancer before and after radiation treatment (2007) (0)
Combined PET-CT assessment of carotid plaques: A human histopathological study (2006) (0)
Measurement of tissue pharmacokinetics of antimicrobial agents by positron emission tomography (1999) (0)
P2-328 Imaging of cerebral amyloid angiopathy with Pittsburgh Compound B (2006) (0)
A new, potent, norepinephrine transporter PET imaging agent (S,S)-[11C]MeNER: Biodistribution study in mice (2006) (0)
P2-268 Amyloid deposition in presymptomatic familial Alzheimer’s disease (2006) (0)
IC-103-03 Amyloid deposition in presymptomatic familial Alzheimer’s disease (2006) (0)
Investigation of MBL-mediated innate immune response to influenza A viral infection using FDG and 18FTPP (2012) (0)
Evaluation of [N-2-fluoropropyl]-2-(4'(methylamino)phenyl)-6-hydroxybenzothiazole as a potential A{beta} amyloid polymerization inhibitor and PET tracer (2010) (0)
METHOD FORMONITORING BLOODFLOW AND METABOLIC UPTAKE IN TISSUE WITH RADIOLABELED ALKANOCACD (2017) (0)
fluorinated gases Imaging obstructed ventilation with NMR using inert (2015) (0)
omarker for assessing signals of efficacy in early-stage AD clinical trials. P2-327 NEUROIMAGE STEREOLOGY: A MARKER FOR BRAIN AGING AND DEMENTIA (2006) (0)
Abstract 3411: Combined PET-CT Assessment of Carotid Plaque Inflammation: A Human Histopathological Study (2006) (0)
Award Number: W81XWH-11-1-0387 TITLE: Viral Oncolytic Therapeutics for Neoplastic Meningitis PRINCIPAL INVESTIGATOR: Mikhail Papisov, PhD CONTRACTING ORGANIZATION: Massachusetts General Hospital (2015) (0)
Targeting proliferating smooth muscle cell phenotype for noninvasive localization of experimental atherosclerotic lesions (1997) (0)
An O-15 PET study of differential brain activation and peripheral autonomic responses in depressed patients during mood induction (2007) (0)
A replication of cerebral metabolic correlates of OCD response to anterior cingulotomy (2007) (0)
POLYBOTIN COMPOUNDS FOR MAGNETIC RESONANCE MAGING AND DRUG DELIVERY RELATED APPLICATIONS (2017) (0)
356. PET receptor studies of major depression with anger attacks (2000) (0)
Prospective morphological and functional evaluation of mucinous pancreatic lesions by PET-CT with surgical-pathology correlation (2007) (0)
Acute ethanol administration stimulates fatty acid metabolism in brown adipose tissue of mice (2006) (0)
Pet O-15 sympton provocation studies of anxiety disorders (1994) (0)
Author ' s personal copy Dopamine release during human emotional processing (2009) (0)
PET Imaging of Neuromodulation (1996) (0)
Optimization of Sn -mannitol formulation for Tc-99m-labeling of hydrazinonicotinamide-conjugated peptides (1996) (0)
Characterization of the reinjection thallium image. (1993) (0)
Abstract 2197: Immune Modulation with Granulocyte/macrophage Colony-stimulating Factor Enhances PET Imaging of Inflamed Atherosclerotic Plaques (2006) (0)
Comparison of uptake of CardioPET, a potential PET tracer for myocardial fatty acid utilization and BFPET, a possible PET blood flow marker in fed vs fasted mice (2011) (0)
Elevated minimum perfusion resistance is an important predictor of the functional status of patients with ischemic heart disease (1996) (0)
Intravascular detection of inflammed atherosclerotic plaques with a novel macrophage-targeted fluorescent photodynamic compound (2003) (0)
Assessment of maximal microvascular dilator capacity in myocardial regions with normal flow reserve: Observations in patients with stable IHD (1996) (0)
266 PET-FDG uptake as a prognostic indicator in gliomas (1995) (0)
Regional FDG hypometabolism associated with amyloid deposition in normal aging (2007) (0)
Biotin connections to target tumors and infection-herd (1995) (0)
Bowel Hot Spots at (2007) (0)
Quo vadis radioimmune imaging. Reply (1990) (0)
Time course of dopamine transporter (DAT) occupancy of a long-acting formulation of dexmethylphenidate (2008) (0)
Synthesis and Evaluation of Novel N-[2-(bisarylmethoxy)ethyl]-N′-aralkyl-α,ω-alkanediamines as Potent and Selective Dopamine Reuptake Inhibitors: seco Analogues of GBR12935 and GBR12909. (2010) (0)
PET imaging of CSF drainage using labeled macromolecular solutes (2012) (0)
FDG uptake at sequential intervals after radiotherapy (RT) or RT of chemo-radiotherapy (CT+RT) and its predictive value for clinical outcome of primary lung cancer (2007) (0)
Measurement of muscle protein synthesis by positron emission tomography with L-[ methyl-1 C ] methionine ( hind limb / arteriovenous difference / stable isotope / paraspinal muscle / dog ) (2005) (0)
Cognitive follow-up in non-demented subjects with evidence of amyloid deposition using Pittsburgh Compound-B (PIB) (2007) (0)
Clinical PET: The Debate Continues—Reply (1992) (0)
FLT PET for rising FDG uptake suggestive of local recurrence after radiotherapy (RT) or chemo-radiotherapy (CT+RT) in lung cancer (2008) (0)
Burn injury increases myocardial uptake of FDG and BFPET but not CardioPET in mice (2011) (0)
In vivo verification of proton beam delivery by PET-CT (2007) (0)
2874 : Clinical Feasibility of PET/CT Image Guidance After Proton Radiotherapy (2006) (0)
The effect of fructose loading on fatty acid uptake in mice (2013) (0)
Current BER Scientists: Principal Investigators (2001) (0)
Uridine is a Marker of Viability in Myocardial Ischemia (1993) (0)
O1-05-01 (2006) (0)
Role of radionuclide studies in drug development and evaluation (1992) (0)
An FDG-PET study of GABAergic treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder (2008) (0)
Continuous monitoring of ventricular function. (1992) (0)
P2-329 Amyloid burden correlates with cognitive function in normal aging, MCI and AD (2006) (0)
PROPHYLACTIC E5 PROTECTS AGAINST THE HEMODYNAMIC CONSEQUENCES OF ENDOTOXIN (LPS) CHALLENGE IN RABBITS (1993) (0)
Positron : Imission Tu MYoear ( _ "-- A Blood Fl MyocarC : am in Patie hie 1107 v blermits (2016) (0)
RECIPROCAL LATERALIZATION OF FRONTAL LOBE FUNCTIONS. AUTHORS' REPLY (1995) (0)
Metabolic Response of Lung Cancer Measured With 18F-FDG PET at Sequential Intervals After Radiochemotherapy (RT + CT) and Its Predictive Power for Tumor Control: Primary Tumor Versus Involved Regional Lymph Node (2014) (0)
PET measurement of maximal myocardial blood flow with adenosine identifies moderate/severe coronary stenosis (1995) (0)
153. Abnormalities in thalamus and prefrontal cortex during episodic object recognition in schizophrenia (2000) (0)
Simultaneous measurement of hepatic uptake of 123I FIAU and 99mTc Annexin-V in woodchuck hepatocellular carcinoma (2007) (0)
Abstract 2390: Metabolic Activity within Periodontal Tissue Correlates with Carotid Plaque Inflammation (2006) (0)
shunt after smoke inhalation measured by PET Alterations in regional ventilation, perfusion, and (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Allan J. Fischman?

Allan J. Fischman is affiliated with the following schools:

Allan J. Fischman's Academic­Influence.com Rankings

Allan J. Fischman's Degrees

Why Is Allan J. Fischman Influential?

Allan J. Fischman's Published Works

Published Works

What Schools Are Affiliated With Allan J. Fischman?

Allan J. Fischman's AcademicInfluence.com Rankings